Podcasts about headache center

So excited to welcome Dr. Hope O'Brien to the next Brain Chat! We'll be discussing Headache and Facial Pain: Migraine and Trigeminal Neuralgia.

What Causes Red Wine Headaches? It May Be QuercetinIt's a common experience: After a glass or two of red wine, relaxation can turn into a pounding headache. This isn't the same thing as a hangover, as the dreaded red wine headache kicks in between 30 minutes and three hours after imbibing.For years, there have been different theories about what causes this phenomenon. But neither sulfites or tannins have been proven to be the culprit. A new theory published in the journal Scientific Reports posits that quercetin, an antioxidant in grape skins, could create a toxic byproduct that leads to headaches.Dr. Morris Levin is one of the authors on this paper. He's the director of the Headache Center at the University of California San Francisco Medical Center, and has spent his career treating patients for migraines and other headache experiences. But Levin says there's not nearly enough funding for headache research as a whole, which leaves a lot of unanswered questions about the origins and meanings of this common ailment.Levin joins guest host Flora Lichtman to discuss red wine headaches, as well as the remaining mysteries of headaches.Worsening Wildfires Are Undoing Air Quality Progress In The USThe Western US has seen both more frequent and more intense wildfires over the past couple decades, leading to lower air quality and increased deaths in the region between 2000 and 2020, according to a new study published in The Lancet Planetary Health journal. While the EPA has made progress in improving air quality in the country, those gains are being undone by smoke from wildfires.The study looked at particulate matter called PM2.5 and a toxic component of it, black carbon. The researchers found that after years of trending downward nationally, the concentration of PM2.5–and the proportion of black carbon within it–began to increase in the West in 2010. This shift was linked to an increase of 670 premature deaths per year in the region.Joining Ira to talk about this and other science news of the week is Rachel Feltman, host of the podcast The Weirdest Thing I Learned This Week. They also discuss a surprise found in the oldest known mosquito fossil, why a national plastic bag recycling program was shut down, and why dwarf planet Eris' surface is a little squishy.  Transcripts for each segment will be available the week after the show airs on sciencefriday.com. To stay updated on all things science, sign up for Science Friday's newsletters.

Dr. Hope O'Brien is back to share the lessons she's learned as a business woman and physician leader. She is the founder and CEO of the Headache Center of Hope in Cincinnati, OH. This is s a very special place where patients get individualized treatment for a wide range of headache disorders. The center provides a wellness-based approach delivered by physicians who have empathy and faith in healing.

Dr. Hope O'Brien is back! She is the founder and CEO of Headache Center of Hope in Mason, Ohio. This business venture is the next chapter in an already exciting, fulfilling career. The center offers a synergistic, holistic approach to treat all sorts of headache disorders. It's not cookie cutter treatment. It truly is individualized to each patient.

I am overjoyed to have Dr. Hope O'Brien as my guest on this inaugural episode in the Next Chapters series! I'm featuring interesting people who have taken risks and reinvented themselves by changing careers, buying or selling businesses, retiring, re-firing, or following their dreams.Dr. O'Brien is a walking, talking living example of courageously writing a new chapter, dreaming a new dream, and fulfilling your purpose and promise.

In this episode, Jess sits down with Dr. Jono Taves, founder of Novera Headache Center to talk about the lesser known root cause of headaches and migraines: neck and shoulder pain! In this episode, you'll learn: -A snippet of Jess's history with migraine headaches and why she reached out to Dr. Taves for support -How to Western model of care treats headaches and migraines and why it is so hard to get real answers and longterm support (besides just a prescription!) -Dr. Taves journey from traditionally trained physical therapist to specializing in headache and migraine patients -How and why a large percentage of headache and migraines stem from neck and shoulder pain -Understanding the migraine "threshold" and how certain triggers (diet, lifestyle, stress, hormones) play a role -Practical tips & tools for treating neck and shoulder immobility and pain to improve headaches and migraines naturally -What it's like to be a patient at Novera Headache Center vs. a traditional doctor or physical therapist office -Jess's experience as a patient at Novera and why she decided to make the trip out to Colorado Springs && so much more! RESOURCES Solo 2.0 Episode: Getting to the Root of Hormonal Headaches & Migraines HERE The Headache Doctor Podcast Episode w/ Dr. Taves & Jess Suchan HERE CONNECT WITH DR. TAVES NoveraHeadacheCenter.com The Headache Doctor Podcast TikTok @theheadachedoctor Instagram @noveraheadachecenter Take the Headache & Migraine Masterclass with code SOLO for 10% off Join the waitlist for the Sam Devise HERE CONNECT WITH US Shoot us an email solo2.0podcast@gmail.com Send us a DM! @solo2.0podcast Follow Rye @ryeburch & Jess @bodyblissbyjess

Migraine – a disease with a strong genetic component – can affect as many as 10% of children and present as early as two years old. The headache is the most prevalent symptom of migraine, but there is a lot more to this disease than many people understand.     This week on Young & Healthy, experts from the Headache Center, Dr. Marielle Kabbouche Samaha and Dr. Shalonda Slater, join us to answer all of your questions about migraine. We discuss the difference between a migraine and a headache of a different origin, the types of migraines, the stages of migraine, and red flags that may indicate a headache is a symptom of something else. Dr. Kabbouche Samaha and Dr. Slater also share how children can adopt healthy habits to improve migraine frequency, treatments that are available for children, and what to do if a migraine starts while at school.    For more information on the Headache Center, please visit https://www.cincinnatichildrens.org/service/h/headache-center.  

Sara Schaefer speaks with two direct care neurologists Hope O'Brien, founder and CEO of Headache Center of Hope in Cincinnati, OH, and Diana Blum, founder of Peninsula Private Neurology in Menlo Park, CA. They discuss what this model of patient care means, their reasons for choosing it, the patient populations and differences in the doctor/patient relationships compared to employed practice, the day-to-day of direct care practice, and how it has impacted their work/life balance.

Dr. Hope O'Brien, headache specialist and Associate Editor for headache at JCN, talks about opening her own clinic for headache medicine – The Headache Center of Hope – in Cincinnati, Ohio. https://www.hcohcincy.com/hope-obrien

Sara Schaefer discusses using combined medical and business degrees with two MD/MBA neurologists Hope O'Brien, founder and CEO of Headache Center of Hope in Cincinnati, OH, and Paul Fu, Chief Medical Officer of Sturdy Memorial Associates, an ambulatory medical system in Massachusetts.

What do you do when you get a migraine? I take an alternating hot and cold shower, that's what works for me. Turns out that is one of the natural ways of soothing our nerves when we have a migraine. In this week's episode on the Growth Island we have a n expert on the topic. Dr. Stephen D. Silberstein MD, a neurologist and headache specialist, he is the Professor of Neurology and Director, Headache Center at Thomas Jefferson University. He is at the forefront of migraine research with numerous peer reviewed publications under his belt (over 300), he is the Co-Director of the national and international Headache Guideline Project and the Chairman, headache research group of the World Federation of Neurology. In this episode we discuss:

The Hartford HealthCare (HHC) Ayer Neuroscience Institute Headache Center and the internationally-recognized Migraine Research Foundation (MRF) recently announced an official, permanent collaboration. In this episode, Hartford HealthCare's Steve Coates talks with the Headache Center's medical director Dr. Brian Grosberg who explains how this one-of-a-kind program is advancing research and treatment in the field of headaches. Check the notes in this episode to learn more about the Headache Center, their research, services and upcoming programs and classes. Or go to HartfordHealthCare.org/Headache. Subscribe or follow Hartford HealthCare's More Life to be notified each time a new episode drops. Just search “Hartford HealthCare” on your favorite podcast platform. Related articleHartford HealthCare, Migraine Research Foundation Announce Collaboration Related episodesSplitting Headaches: Episode 1 with Dr. Nicole GillSplitting Headaches: Episode 2 with Dr. Joe CasalyHartford HealthCare programs and classesView or search by category

Clinical Significance of Micronutrient Supplementation in Critically Ill COVID-19 Patients with Severe ARDS  University Hospital Wuerzburg (Germany), June 12, 2021 Abstract The interplay between inflammation and oxidative stress is a vicious circle, potentially resulting in organ damage. Essential micronutrients such as selenium (Se) and zinc (Zn) support anti-oxidative defense systems and are commonly depleted in severe disease. This single-center retrospective study investigated micronutrient levels under Se and Zn supplementation in critically ill patients with COVID-19 induced acute respiratory distress syndrome (ARDS) and explored potential relationships with immunological and clinical parameters. According to intensive care unit (ICU) standard operating procedures, patients received 1.0 mg of intravenous Se daily on top of artificial nutrition, which contained various amounts of Se and Zn. Micronutrients, inflammatory cytokines, lymphocyte subsets and clinical data were extracted from the patient data management system on admission and after 10 to 14 days of treatment. Forty-six patients were screened for eligibility and 22 patients were included in the study. Twenty-one patients (95%) suffered from severe ARDS and 14 patients (64%) survived to ICU discharge. On admission, the majority of patients had low Se status biomarkers and Zn levels, along with elevated inflammatory parameters. Se supplementation significantly elevated Se (p = 0.027) and selenoprotein P levels (SELENOP; p = 0.016) to normal range. Accordingly, glutathione peroxidase 3 (GPx3) activity increased over time (p = 0.021). Se biomarkers, most notably SELENOP, were inversely correlated with CRP (rs = −0.495), PCT (rs = −0.413), IL-6 (rs = −0.429), IL-1β (rs = −0.440) and IL-10 (rs = −0.461). Positive associations were found for CD8+ T cells (rs = 0.636), NK cells (rs = 0.772), total IgG (rs = 0.493) and PaO2/FiO2ratios (rs = 0.504). In addition, survivors tended to have higher Se levels after 10 to 14 days compared to non-survivors (p = 0.075). Sufficient Se and Zn levels may potentially be of clinical significance for an adequate immune response in critically ill patients with severe COVID-19 ARDS.       Pilot Study of the Tart Cherry Juice for the Treatment of Insomnia and Investigation of Mechanisms Louisiana State University, June 20, 2021 Insomnia is common in the elderly and is associated with chronic disease, but use of hypnotics increases the incidence of falls. Montmorency tart cherry juice has improved insomnia by self-report questionnaire. Study Question:  Is insomnia confirmed by polysomnography and is tryptophan availability a potential mechanism for treating insomnia? Study Design:  A placebo-controlled balanced crossover study with subjects older than 50 years and insomnia were randomized to placebo (2 weeks) or cherry juice (2 weeks) (240 mL 2 times/d) separated by a 2-week washout. Measures and Outcomes:  Sleep was evaluated by polysomnography and 5 validated questionnaires. Serum indoleamine 2,3-dioxygenase (IDO), the kynurenine-to-tryptophan ratio, and prostaglandin E2 were measured. In vitro, Caco-2 cells were stimulated with interferon-gamma, and the ability of cherry juice procyanidin to inhibit IDO which degrades tryptophan and stimulates inflammation was measured. The content of procyanidin B-2 and other major anthocyanins in cherry juice were determined. Results:  Eleven subjects were randomized; 3 with sleep apnea were excluded and referred. The 8 completers with insomnia increased sleep time by 84 minutes on polysomnography (P = 0.0182) and sleep efficiency increased on the Pittsburgh Sleep Quality Index (P = 0.03). Other questionnaires showed no significant differences. The serum kynurenine-to-tryptophan ratio decreased, as did the level of prostaglandin E2 (both P < 0.05). In vitro, cherry juice procyanidin B-2 dose-dependently inhibited IDO. Conclusions:  Cherry juice increased sleep time and sleep efficiency. Cherry juice procyanidin B-2 inhibited IDO, increased tryptophan availability, reduced inflammation, and may be partially responsible for improvement in insomnia.         Many with migraines have vitamin deficiencies, says study   Cincinnati Children's Hospital, June 10, 2021    A high percentage of children, teens and young adults with migraines appear to have mild deficiencies in vitamin D, riboflavin and coenzyme Q10—a vitamin-like substance found in every cell of the body that is used to produce energy for cell growth and maintenance.   These deficiencies may be involved in patients who experience migraines, but that is unclear based on existing studies.   "Further studies are needed to elucidate whether vitamin supplementation is effective in migraine patients in general, and whether patients with mild deficiency are more likely to benefit from supplementation," says Suzanne Hagler, MD, a Headache Medicine fellow in the division of Neurology at Cincinnati Children's Hospital Medical Center and lead author of the study.   Dr. Hagler and colleagues at Cincinnati Children's conducted the study among patients at the Cincinnati Children's Headache Center. She will present her findings at 9:55 am Pacific time Friday, June 10, 2016 at the 58th Annual Scientific Meeting of the American Headache Society in San Diego.   Dr. Hagler's study drew from a database that included patients with migraines who, according to Headache Center practice, had baseline blood levels checked for vitamin D, riboflavin, coenzyme Q10 and folate, all of which were implicated in migraines, to some degree, by previous and sometimes conflicting studies. Many were put on preventive migraine medications and received vitamin supplementation, if levels were low. Because few received vitamins alone, the researchers were unable to determine vitamin effectiveness in preventing migraines.   She found that girls and young woman were more likely than boys and young men to have coenzyme Q10 deficiencies at baseline. Boys and young men were more likely to have vitamin D deficiency. It was unclear whether there were folate deficiencies. Patients with chronic migraines were more likely to have coenzyme Q10 and riboflavin deficiencies than those with episodic migraines.   Previous studies have indicated that certain vitamins and vitamin deficiencies may be important in the migraine process. Studies using vitamins to prevent migraines, however, have had conflicting success.     Research suggests mask-wearing can increase struggles with social anxiety University of Waterloo (Canada), June 21, 2021 People who struggle with social anxiety might experience increased distress related to mask-wearing during and even after the COVID-19 pandemic. A paper authored by researchers from the University of Waterloo's Department of Psychology and Centre for Mental Health Research and Treatment also has implications for those who haven't necessarily suffered from social anxiety in the past. "The adverse effects of the COVID-19 pandemic on mental health outcomes, including anxiety and depression, have been well-documented," said David Moscovitch, professor of clinical psychology and co-author of the paper. "However, little is known about effects of increased mask-wearing on social interactions, social anxiety, or overall mental health. "It is also possible that many people who didn't struggle with social anxiety before the pandemic may find themselves feeling more anxious than usual as we emerge out of the pandemic and into a more uncertain future -- especially within social situations where our social skills are rusty and the new rules for social engagement are yet to be written." Social anxiety is characterized by negative self-perception and fear that one's appearance or behaviour will fail to conform with social expectations and norms. Social anxiety disorder is an extreme manifestation that affects up to 13 per cent of the population.  The researchers reviewed existing literature addressing three factors that they hypothesized might contribute to social anxiety associated with mask-wearing: hypersensitivity to social norms, bias in the detection of social and emotional facial cues, and propensity for self-concealment as a form of safety behaviour. "We found that mask-wearing by people with social anxiety is likely to be influenced by their perception of social norms and expectations, which may or may not be consistent with public-health guidelines and can vary widely by region and context," said Sidney Saint, an undergraduate psychology student at Waterloo and lead author of the paper. The paper also highlights that people with social anxiety have difficulty detecting ambiguous social cues and are likely to interpret them negatively. These individuals also tend to worry about sounding incomprehensible or awkward. "We believe that both issues are likely to be magnified during interactions with masks," Saint said. Another highlighted impact is that masks can function as a type of self-concealment strategy that enables people with social anxiety to hide their self-perceived flaws. Therefore, the desire for self-concealment may motivate their use of masks over and above their desire to protect themselves from contagion. "Due to their self-concealing function, masks may be difficult for some people to discard even when mask-wearing is no longer required by public health mandates," Saint said.  In addition to contributing insights to guide clinicians toward effective assessment and treatment, the paper shows that people with social anxiety may be particularly vulnerable to periods of norm transitions where expectations for mask-wearing are in flux or become a matter of personal choice.       Going with your gut can result in better decision-making than using detailed data methods, study shows City University London, June 21, 2021 Managers who use their gut instinct together with simple decision-making strategies may make equally good, but faster, decisions as those who use data to reach an outcome, a new study has found. The report, co-authored by academics at the Business School (formerly Cass), King's Business School, and the University of Malta, finds that the reliance on data analysis in decision-making might be counterproductive as this reduces decision-making speed without ensuring more accuracy. The research, based on information from 122 advertising, digital, publishing, and software companies, finds that using data to inform decision making under high uncertainty is often not optimal. This may explain why 12 different publishers initially rejected the opportunity to publish "Harry Potter and the Philosopher's Stone' – because it had no data to inform its potential. A recent survey revealed that 92 percent of Fortune 1000 companies were reporting increased investment in data initiatives, although it appears this may not always be necessary. The authors asked managers how they made decisions on their most recent innovation project, including the extent to which they used data, instinct, and other simple heuristics (mental strategies). The findings outlined that among those decision-making methods were: Majority—choosing what the most people wanted Tallying—picking the choice with the greatest quantity of positive points Experience—selecting the option that the most experienced individual on the team wanted. Managers were asked whether they think they made the right decision and how fast they were in reaching that decision. Results showed that managers relied on their own instinct as much as data, using 'tallying' more than any other metric. Dr. Oguz A. Acar, Reader in Marketing at the Business School and co-author of the report, said: "This research shows that data-driven decision-making is not the panacea in all situations and may not result in increased accuracy when facing uncertainty. "Under extreme uncertainty, managers, particularly those with more experience, should trust the expertise and instincts that have propelled them to such a position. The nous developed over years as a leader can be a more effective than an analytical tool which, in situations of extreme uncertainty, could act as a hindrance rather than a driver of success." "Choosing among alternative new product development projects: The role of heuristics" is published in Psychology and Marketing.   Pretreatment by rosemary extract or cell transplantation improves memory deficits of Parkinson disease Damghan University (Iran) June 21 2021 According to news originating from Damghan, Iran, research stated, “The therapeutic effect of adipose tissue-derived stem cells (ADSCs) or RE on hippocampal neurogenesis and memory in Parkinsonian rats were investigated. Male rats were lesioned by bilateral intra-nigral injections of 6-OHDA and divided into six groups: 1. Lesion 2 and 3: RE and water groups were lesioned rats pretreated with RE or water, from 2weeks before neurotoxin injection and treated once a day for 8weeks post lesion. 4&5: Cell and alpha-MEM (alpha-minimal essential medium) received intravenous injection of BrdU-labeled ADSCs or medium, respectively from 10days post lesion until 8weeks later. 6: Sham was injected by saline instead of neurotoxin.” Our news journalists obtained a quote from the research from Damghan University, “Memory was assessed using Morris water Maze (MWM), one week before and at 1, 4 and 8weeks post 6-OHDA lesion. After the last probe, the animals were sacrificed and brain tissue obtained. Paraffin sections were stained using cresyl violet, anti-BrdU (Bromodeoxyuridine / 5-bromo-2'-deoxyuridine), anti-GFAP (Glial fibrillary acidic protein) and anti-TH antibodies. There was a significant difference of time spent in the target quadrant between groups during probe trial at 4 and 8 weeks' post-lesion. Cell and RE groups spent a significantly longer period in the target quadrant and had lower latency as compared with lesion. Treated groups have a significantly higher neuronal density in hippocampus compared to water, alpha-MEM and lesion groups. BrdU positive cells were presented in lesioned sites. The GFAP (Glial fibrillary acidic protein) positive cells were reduced in treated and sham groups compared to the water, alpha-MEM and lesion groups.” According to the news editors, the research concluded: “Oral administration of RE (Rosemary extract) or ADSCs injection could improve memory deficit in the Parkinsonian rat by neuroprotection.”     Inadequate vitamin D levels associated with interstitial lung disease Johns Hopkins University, June 20 2021.    An article appearing in the Journal of Nutrition documents a link between decreased vitamin D levels and a greater risk of early signs of interstitial lung disease (ILD), a group of disorders characterized by inflammation and scarring that can lead to lung damage. Although ILD can be caused by environmental and other factors, some cases have unknown causes. The investigation included 6,302 participants in the Multi-Ethnic Study of Atherosclerosis who had information available concerning their initial serum 25-hydroxyvitamin D concentrations and computed tomography (CT) imaging that included partial views of the lungs. Ten years after enrollment, 2,668 participants had full lung CT scans that were evaluated for presence of scar tissue and other abnormalities. Subjects who had deficient vitamin D levels of less than 20 ng/mL had more spots on their lungs that were suggestive of damage in comparison with subjects whose vitamin D was adequate. Among those who had full lung CT scans, deficient or intermediate (between 20-30 ng/mL) vitamin D levels were associated with a 50-60% greater risk of abnormalities suggestive of ILD. "We knew that the activated vitamin D hormone has anti-inflammatory properties and helps regulate the immune system, which goes awry in ILD," commented senior author Erin Michos, MD, MHS. “There was also evidence in the literature that vitamin D plays a role in obstructive lung diseases such as asthma and COPD, and we now found that the association exists with this scarring form of lung disease too." "Our study suggests that adequate levels of vitamin D may be important for lung health,” she concluded. “We might now consider adding vitamin D deficiency to the list of factors involved in disease processes, along with the known ILD risk factors such as environmental toxins and smoking.”

Migraine-associated gene expression in cell types of the central and peripheral nervous system, Predicting erenumab adverse events with single-cell genomics, and Transcriptional Reprogramming of Distinct Peripheral Sensory Neuron Subtypes after Axonal Injury Prof. William Renthal is the Director of Research at the John Graham Headache Center at Brigham and Women’s Hospital and an Assistant Professor of Neurology at Harvard Medical School. His research focuses on the use of molecular genetics to develop therapeutic strategies for headache and pain. --- Send in a voice message: https://anchor.fm/scientificsense/message Support this podcast: https://anchor.fm/scientificsense/support

Dr. Andrew Blumenfeld, MD, director of the Headache Center of Southern California discusses the often misunderstood condition of migraine, how the disease is typically managed, and the latest development in treatment options. VYEPTI™ (eptinezumab-jjmr) is a prescription medicine used for the preventive treatment of migraine in adults.

Josie Bidwell welcomes in Christina Treppendahl, from the Headache Center in Ridgeland, to discuss something almost everyone can identify with...headaches. See acast.com/privacy for privacy and opt-out information.

In this episode you'll learn about Hartford Healthcare's innovative multidisciplinary headache center in Connecticut, which uses a collaborative care model and administers tailored treatment plans.The scope of their services is quite expansive. As the only comprehensive Center of its kind in its region, the Center connect the world’s most advanced technology and the most current treatment options to give patients relief and/or freedom from the debilitating pain of headache. We should all hope that this type of center opens up in other states across the country in the near future.  View the video of this podcast here: https://youtu.be/dQemMfxsP-U     *The contents of this podcast/video are intended for general informational purposes only and do not constitute medical or legal advice; the content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. The Association of Migraine Disorders does not recommend or endorse any specific course of treatment, products, procedures, opinions, or other information that may be mentioned. Reliance on any information provided by this content is solely at your own risk.

Dr. William Young from the Jefferson University Headache Center talks with AMD's Jim Carleton about the Headache Center and how it is run. They also discuss migraine stigma and Dr. Young's recommended terms to use when speaking about migraine and migraine patients. Lastly, Dr. Young gives his view of hope for the future of migraine treatment options.   *The contents of this podcast/video are intended for general informational purposes only and do not constitute medical or legal advice; the content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. The Association of Migraine Disorders does not recommend or endorse any specific course of treatment, products, procedures, opinions, or other information that may be mentioned. Reliance on any information provided by this content is solely at your own risk.

This week Dr. Josie Bidwell welcomes Christina Treppendahl from The Headache Center to the show in-studio to talk about migraines and all kinds of headaches.The Headache Center - on FacebookThe Migraine Coach AppMigraine Buddy App See acast.com/privacy for privacy and opt-out information.

Guest: Peter Goadsby, MD, PhD Host: Mary Leuchars, MD Occipital Nerve Stimulation has recently emerged as a novel form of therapy for patients with intractable cluster headaches. Could it be the hallmark of a new era in stimulation therapies for primary headache syndromes? Joining host Dr. Mary Leuchars to share insights on this subject is neurologist Dr. Peter Goadsby, director of UCSF's Headache Center and a world expert on trigeminal autonomic cephalgias, or TACs.

Guest: Peter Goadsby, MD, PhD Host: Mary Leuchars, MD Trigeminal autonomic cephalgias, or TACs, and their classifications are enough to give any clinician a headache. How can physicians better appreciate this condition to enhance clinical practice? Dr. Peter Goadsby, director of the Headache Center at the University of California, San Francisco, Medical Center and a world expert on TAC, joins host Dr. Mary Leuchars to update listeners on this unique group of headache conditions.

Guest: Peter Goadsby, MD, PhD Host: Mary Leuchars, MD Trigeminal autonomic cephalgias, or TACs, and their classifications are enough to give any clinician a headache. How can physicians better appreciate this condition to enhance clinical practice? Dr. Peter Goadsby, director of the Headache Center at the University of California, San Francisco, Medical Center and a world expert on TAC, joins host Dr. Mary Leuchars to update listeners on this unique group of headache conditions.